Press Releases - 2021-07-13

Date	Title	Company
13-Jul-2021	Almac Group’s Charnwood Site Achieves Globally Recognised Health & Safety and Environmental Management System Certifications	Almac Group
13-Jul-2021	Mounting evidence suggests Sputnik COVID vaccine is safe and effective	Nature
13-Jul-2021	Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC	Novasep
13-Jul-2021	Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection	Arbutus Biopharma
13-Jul-2021	THIN®, one of Europe’s largest healthcare databases, with real-world longitudinal data on 69 million anonymized patients, arrives in Italy	Cegedim Group
13-Jul-2021	UK Pharma, Life Sciences and Medical Technology sectors see R&D spend hold up despite Brexit and Covid-19, survey reveals	MHA
13-Jul-2021	Global Fc Fusion Protein for Autoimmune Disease Market Regional Study, Upcoming Trends, Research Strategies and Growth Analysis Report 2021 to 2026	CDN Newswire
13-Jul-2021	4D pharma announces publication of preclinical research showing single strain Megasphaera Massiliensis improves activity of CAR-T	4D pharma
13-Jul-2021	Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management	Parexel
13-Jul-2021	New approach will help identify drugs that can ‘glue’ proteins together	University of Birmingham
13-Jul-2021	Athersys to Host Second Quarter Financial Results Call	Businesswire
13-Jul-2021	Tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population across Phase II and III clinical trials	AstraZeneca
13-Jul-2021	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC	Immutep
13-Jul-2021	F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors	F-star Therapeutics
13-Jul-2021	Global Homozygous Familial Hypercholesterolemia Clinical Trials Review - H1, 2021 - ResearchAndMarkets.com	Businesswire
13-Jul-2021	FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial	Businesswire
13-Jul-2021	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
13-Jul-2021	Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases	Muna Therapeutics
13-Jul-2021	New blood test for the diagnostics of frontotemporal dementia	University of Eastern Finland
13-Jul-2021	Global Fc Fusion Protein for Haemophilia Market Feasibility Analysis, Application, Growing Trends and Forecast 2021-2026	CDN Newswire